dr. camidge on the fda approval of pembrolizumab for squamous nsclc
Published 5 years ago • 357 plays • Length 0:36Download video MP4
Download video MP3
Similar videos
-
0:30
copy of dr. camidge on the keynote-024 trial in nsclc
-
0:35
dr. farago on the fda approval of pembrolizumab for lower pd-1 cutoff nsclc
-
1:27
dr. camidge on the keynote-024 trial in nsclc
-
1:51
dr. camidge discusses treatment of patients with alk nsclc
-
1:52
dr. camidge on optimal therapy in egfr nsclc
-
1:15
dr. spigel on fda approval of pembrolizumab/chemo combo in nsclc
-
5:54
pembrolizumab in newly diagnosed squamous nsclc
-
3:02
dr. ou on the fda approval of pembrolizumab in sclc
-
1:00
dr. camidge on phase i study with azd9291 in nsclc
-
1:54
dr. wakelee on fda approval of frontline pembrolizumab in nsclc
-
2:04
dr. gandhi on pembrolizumab/chemo findings in nsclc and fda approval
-
1:51
dr. camidge on biomarker combinations in nsclc
-
1:58
dr. camidge on mechanisms of resistance to tkis in nsclc
-
1:04
dr. monk on the fda approval of pembrolizumab in cervical cancer
-
0:38
dr. petrylak on fda approval of pembrolizumab in bladder cancer
-
1:44
dr. ferris on impact of fda approval of pembrolizumab in patients with head and neck cancer
-
4:52
the keynote-407 trial in metastatic squamous nsclc
-
1:42
dr. hamid on the fda approval of pembrolizumab in merkel cell carcinoma
-
1:04
dr. gutierrez on the safety profile of pembrolizumab-based combos in nsclc